Recent updates

March 04, 2018

Korean language article on our company's market prospects. ViroCure has received a Pre-IPO placement of ₩6 billion with various investors. ViroCure will be listed on KOSDAQ in 2-3 years; investors estimate a value of ₩36 billion after this phase of funding.

February 06, 2018

Interview with CEO Dr. Manbok Kim on the origins and developments behind ViroCure.

November 13, 2017

ViroCure USA press release published

June 18, 2017

ViroCure interview with biomedical review Journal regarding oncolytic viruses

April 27, 2017

ViroCure interview with Biospectator Journal regarding oncolytic viruses

Please reload

©  ViroCure 2018

#119, 3802 Spectrum Blvd. Tampa, FL 33612

Tel: 813-615-9367

Fax: 813-615-9334